v3.21.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Expenses:    
Selling, general and administrative expenses $ 1,176,455 $ 997,896
Research and development expenses 1,631,795 510,624
Loss from Operations (2,808,250) (1,508,520)
Other Income:    
Interest income, net (2,959) (2,633)
Change in fair value of derivative liabilities (346,129)
Other expense (32,405)
Total Other Income (35,364) (348,762)
Net Loss $ (2,772,886) $ (1,159,758)
Net Loss Per Basic and Diluted Common Share: $ (0.48) $ (1.57)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted 5,741,212 737,275

Source